The forkhead box M1 (FOXM1) expression and antitumor effect of FOXM1 inhibition in malignant rhabdoid tumor

[1] Abuzeid WM(2009)Molecular disruption of RAD50 sensitizes human tumor cells to cisplatin-based chemotherapy J Clin Invest 119 1974-1985

[2] Jiang X(1978)Histopathology and prognosis of Wilms tumor results from the first National Wilms’ tumor study Cancer 41 1937-1948

[3] Shi G(1999)Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors Cancer Res 59 74-79

[4] Beckwith JB(2010)FoxM1 mediates resistance to herceptin and paclitaxel Cancer Res 70 5054-5063

[5] Palmer NF(2009)Intensive multimodality treatment for children with newly diagnosed CNS atypical teratoid rhabdoid tumor J Clin Oncol 27 385-389

[6] Biegel JA(2006)Chemosensitization to cisplatin by inhibitors of the Fanconi anemia/BRCA pathway Mol Cancer Ther 5 952-961

[7] Zhou JY(2015)FOXM1 confers to epithelial-mesenchymal transition, stemness and chemoresistance in epithelial ovarian carcinoma cells Oncotarget 6 2349-2365

[8] Rorke LB(2013)FOXM1 is an oncogenic mediator in Ewing sarcoma PLoS ONE 8 1-7

[9] Carr JR(2015)FOXM1 targets XIAP and Survivin to modulate breast cancer survival and chemoresistance Cell Signal 27 2496-2505

[10] Park HJ(2018)Cell cycle arrest through indirect transcriptional repression by p53: i have a DREAM Cell Death Differ 25 114-132

[1] Abuzeid WM(2009)Molecular disruption of RAD50 sensitizes human tumor cells to cisplatin-based chemotherapy J Clin Invest 119 1974-1985

[2] Jiang X(1978)Histopathology and prognosis of Wilms tumor results from the first National Wilms’ tumor study Cancer 41 1937-1948

[3] Shi G(1999)Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors Cancer Res 59 74-79

[4] Beckwith JB(2010)FoxM1 mediates resistance to herceptin and paclitaxel Cancer Res 70 5054-5063

[5] Palmer NF(2009)Intensive multimodality treatment for children with newly diagnosed CNS atypical teratoid rhabdoid tumor J Clin Oncol 27 385-389

[6] Biegel JA(2006)Chemosensitization to cisplatin by inhibitors of the Fanconi anemia/BRCA pathway Mol Cancer Ther 5 952-961

[7] Zhou JY(2015)FOXM1 confers to epithelial-mesenchymal transition, stemness and chemoresistance in epithelial ovarian carcinoma cells Oncotarget 6 2349-2365

[8] Rorke LB(2013)FOXM1 is an oncogenic mediator in Ewing sarcoma PLoS ONE 8 1-7

[9] Carr JR(2015)FOXM1 targets XIAP and Survivin to modulate breast cancer survival and chemoresistance Cell Signal 27 2496-2505

[10] Park HJ(2018)Cell cycle arrest through indirect transcriptional repression by p53: i have a DREAM Cell Death Differ 25 114-132